UGDH Antikörper (C-Term)
Kurzübersicht für UGDH Antikörper (C-Term) (ABIN926700)
Target
Alle UGDH Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Aufreinigung
- Purified
-
Immunogen
- UGDH antibody was raised in rabbit using the C terminal of µgDH as the immunogen
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator.
-
Kommentare
-
UGDH Blocking Peptide, (ABIN5616897), is also available for use as a blocking control in assays to test for specificity of this µgDH antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- UGDH (UDP-Glucose 6-Dehydrogenase (UGDH))
-
Andere Bezeichnung
- UGDH
-
Hintergrund
- The protein encoded by this gene converts UDP-glucose to UDP-glucuronate and thereby participates in the biosynthesis of glycosaminoglycans such as hyaluronan, chondroitin sulfate, and heparan sulfate. These glycosylated compounds are common components of the extracellular matrix and likely play roles in signal transduction, cell migration, and cancer growth and metastasis. The expression of this gene is up-regulated by transforming growth factor beta and down-regulated by hypoxia. Synonyms: Polyclonal UGDH antibody, Anti-UGDH antibody, UDP-glucose 6-dehydrogenase antibody, GDH antibody, UDP-GlcDH antibody, UDPGDH antibody, UGD antibody.
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-